IDO1 and cancer: These studies are consistent with clinical observations that HPV+ cervical lesions express high levels of IDO1 (Kobayashi et al., 2008), suggesting that IDO1+ DCs may drive cancer progression by generating Tregs and/or inducing T cell anergy.